Among participants with no history of major psychopathology, there is no association between semaglutide and depression and suicidality.

Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Two new studies published in JAMA Internal Medicine do not ...

Semaglutide, the popular anti-obesity medication originally developed to treat diabetes, continues to show cardiovascular ...

Novo Nordisk's Wegovy label update receives a positive opinion from the EMA's CHMP, highlighting improvements in heart ...

Novo Nordisk receives a positive opinion from the CHMP for a label update of Wegovy to reflect reduced heart failure symptoms ...

Researchers examined data from the Semaglutide Treatment Effect in People with obesity (STEP) trials – STEP 1, 2, 3, and 5.

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or suicidal behavior in persons without known major mental health disorders, ...

Taking the weight loss medication semaglutide did not increase the risk of depressive symptoms, suicidal thoughts, or ...

Tom Nolan reviews this week’s research You never have to wait too long for a trial of a new drug for migraine. The latest one is Lu AG09222, a monoclonal antibody to pituitary adenylate ...

Researchers examined data from the Semaglutide Treatment Effect in People with Obesity (STEP) trials – STEP 1, 2, 3, and 5. These studies were crucial in gaining approval from the FDA to use ...

Researchers examined data from the Semaglutide Treatment Effect in People with obesity (STEP) trials—STEP 1, 2, 3, and 5. These studies were crucial in gaining approval from the FDA to use ...